This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated VAMP2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-VAMP2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~12.7 kDa | |
| Gel | 15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M02331-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | mouse brain lysate (catalog M02331-1) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02331-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
VAMP2 is predicted at 12.7 kDa; membrane localization and residue 2 acetylation are documented, but neither establishes a different migration position.
| Band near 12.7 kDa | consistent with the predicted VAMP2 size; confirm identity with antibody controls |
| Weak or absent band in soluble lysate | VAMP2 is a vesicle membrane protein and may be underrepresented in this fraction |
| Stronger band in a vesicle membrane fraction | consistent with VAMP2 localization to synaptic vesicle membranes |
| No distinct acetylation-related doublet | N-acetylserine at residue 2 does not establish a resolvable shift |
| UniProt predicted mass | sets a 12.7 kDa reference, not a measured migration position |
| 116-amino-acid sequence | underlies the predicted mass; no separate size shift is established |
| N-acetylserine at residue 2 | is documented, but no resolvable band shift is established |
| Single-pass type IV membrane localization | affects recovery from samples; no apparent size shift is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | VAMP2 may be underrepresented if vesicle membranes are poorly recovered | check a membrane-containing fraction and sample preparation |
| Band higher than expected | the supplied features do not establish an upward migration shift | check antibody specificity and compare with a VAMP2-positive sample |
| Band lower than expected | a lower band has no established feature-based assignment | check antibody specificity and sample integrity |
| Multiple bands | the single listed isoform does not establish distinct VAMP2 bands | compare positive and negative controls to identify the specific band |
| Weak or no signal | low recovery of vesicle membrane material may reduce VAMP2 signal | assess membrane recovery and use a VAMP2-positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for VAMP2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-VAMP2 rabbit monoclonal antibody for Western blotting. Its reported reactivity is human, mouse, and rat; the supplied WB image shows VAMP2 expression in mouse brain lysate. Other sample contexts are not shown.
Which to pick: M02331-1 is the only listed option. Choose it when its reported reactivity fits your sample; the supplied WB image documents mouse brain lysate, so assess other samples with appropriate controls.